JANE STREET GROUP, LLC - RECURSION PHARMACEUTICALS IN ownership

RECURSION PHARMACEUTICALS IN's ticker is and the CUSIP is 75629V954. A total of 3 filers reported holding RECURSION PHARMACEUTICALS IN in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
JANE STREET GROUP, LLC ownership history of RECURSION PHARMACEUTICALS IN
ValueSharesWeighting
Q2 2024$496,500
-74.4%
66,200
-65.9%
0.00%
Q1 2024$1,936,174
+461.0%
194,200
+454.9%
0.00%
Q4 2023$345,100
-39.9%
35,000
-53.3%
0.00%
Q3 2023$573,750
+270.2%
75,000
+294.7%
0.00%
Q2 2022$155,00019,0000.00%
Other shareholders
RECURSION PHARMACEUTICALS IN shareholders Q2 2022
NameSharesValueWeighting ↓
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
JANE STREET GROUP, LLC 19,000$155,0000.00%
SIMPLEX TRADING, LLC 11,300$91,0000.00%
View complete list of RECURSION PHARMACEUTICALS IN shareholders